INVO Bioscience, Inc. 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by INVO Bioscience, Inc. (INVO) on September 1, 2023, covering events occurring on August 31, 2023. The company is incorporated in Nevada and trades on The Nasdaq Stock Market LLC under the symbol "INVO".
Key Financial Metrics and Transaction Details
The filing details a new financing arrangement rather than standard periodic financial results. Key metrics from the transaction include:
- Receivables Purchased: $746,750
- Gross Purchase Price: $515,000
- Net Cash Proceeds: $134,018
- Application of Proceeds: $390,892 was immediately applied to repay a prior Merchant Cash Advance Agreement dated July 19, 2023.
- Repayment Terms: Weekly payments of $16,594 until the purchase price is repaid.
- Collateral: The company granted a security interest in its accounts, including deposit accounts and accounts receivable.
Material Changes
The primary material change is the entry into a new Standard Merchant Cash Advance Agreement. This transaction resulted in a net cash inflow of $134,018 after settling a significant portion of a previous obligation. The filing does not provide comparative financial data (revenue, profit, or margins) for the period.
Outlook, Risks, and Management Commentary
Use of Proceeds: Management intends to use the net proceeds for working capital and general corporate purposes.
Repayment Conditions: The agreement includes specific reduction clauses for the receivables amount based on repayment timing:
- Repayment within 30 days reduces receivables to $643,750.
- Repayment between days 31 and 60 reduces receivables to $674,650.
Investor Verification Checklist
- Verify the full terms of the Standard Merchant Cash Advance Agreement in Exhibit 10.1.
- Confirm the company's ability to meet the weekly payment obligation of $16,594 given current cash flow.
- Assess the impact of the security interest on the company's remaining unencumbered assets.
- Review the status of the prior July 19, 2023 agreement to ensure the $390,892 repayment fully satisfied that specific obligation.